Form 6-K Intercure Ltd. For: Apr 30
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934
For the month of April 2026
Commission File Number: 001-40614
INTERCURE LTD.
(Translation of registrant’s name into English)
85 Medinat ha-Yehudim Street
Herzliya, 4676670, Israel
Tel: +972 77 460 5012
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
On April 30, 2026, InterCure Ltd. issued a press release titled “InterCure Announces 2025 Results with NIS 270 Million in Revenue and Positive Operating Cash Flow” a copy of which is furnished as Exhibit 99.1 with this report of foreign private issuer on Form 6-K.
| Exhibit No. | ||
| 99.1 | Press Release issued by InterCure Ltd. on April 30, 2026, titled “InterCure Announces 2025 Results with NIS 270 Million in Revenue and Positive Operating Cash Flow.” |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| INTERCURE LTD. | |
| Date: May 1, 2026 | /s/ Amos Cohen |
| Amos Cohen | |
| Chief Financial Officer |
ATTACHMENTS / EXHIBITS